Potential of tolerogenic dendritic cells for transplantation

Seminars in Immunology

Volumn 13, Issue 5, 2001, Pages 323-335

  Morelli, Adrian E ^a   Hackstein, Holger ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Dendritic cells; Gene therapy; Tolerance; Transplantation

Indexed keywords

ALLOANTIGEN;

ANTIGEN PRESENTING CELL; DENDRITIC CELL; GENE THERAPY; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; ORGAN TRANSPLANTATION; REVIEW; T LYMPHOCYTE;

EID: 0034885989     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2001.0328     Document Type: Article

References (104)

1. Dendritic cells
2. Immunobiology of dendritic cells
3. Tolerance, danger, and the extended family
4. Danger signals: SOS to the immune system
5. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection
6. Migration and maturation of Langerhans cells in skin transplants and explants
7. Vigorous allograft rejection in the absence of danger
8. Dendritic cells capable of stimulating T cells in germinal centers
9. Toward a role of dendritic cells in the germinal center reaction: Triggering of B cell proliferation and isotype switching
10. Studies of the role of the thymic environment in the induction of tolerance to MHC antigens
11. Does T-cell tolerance require a dedicated antigen-presenting cell?
12. Are dendritic cells the key to liver transplant tolerance?
13. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody
14. The induction of tolerance by dendritic cells that have captured apoptotic cells
15. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
16. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells
17. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
18. - induce alloantigenspecific hyporesponsiveness in murine T lymphocytes
19. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro
20. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival
21. -) prolong cardiac allograft survival in nonimmunosuppressed recipients
22. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation
23. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo
24. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival
25. Prolonged skin allograft survival in mice treated with Flt3-ligand-induced dendritic cells and anti-CD154 monoclonal antibody
26. Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
27. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
28. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb
29. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells
30. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: Association with NF-kappaB inhibition
31. Glucocorticoids affect human dendritic cell differentiation and maturation
32. Differential effects of corticosteroids during different stages of dendritic cell maturation
33. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells
34. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation
35. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin
36. Aspirin inhibits the maturation and immunostimulatory function of murine myeloid dendritic cells in vitro and in vivo
37. Induction of tolerance by IL-10-treated dendritic cells
38. Effect of interleukin-10 on dendritic cell maturation and function
39. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells
40. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: Association with reduced nuclear translocation of nuclear factor kappa B
41. Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin
42. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells
43. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal
44. + T cells
45. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood
46. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide
47. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity
48. Freshly isolated Peyer's patch, but not spleen dendritic cells produce interleukin-10 and induce the differentiation of T helper type 2 cells
49. Effects of liver-derived dendritic cell progenitors on Th1-and Th2-like cytokine responses in vitro and in vivo
50. Immunosuppressive effects of apoptotic cells
51. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells
52. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
53. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
54. Natural adjuvants: Endogenous activators of dendritic cells
55. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
56. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
57. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection
58. Interleukin-13, in combination with anti-interleukin-12, increases graft prolongation after portal venous immunization with cultured allogeneic bone marrow-derived dendritic cells
59. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFβ and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2
60. Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promotes the development of dendritic cells that drive CD4+ T cells toward Th2 responses
61. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
62. Modulating the immune response with dendritic cells and their growth factors
63. Development of CD8α-positive dendritic cells from a common myeloid progenitor
64. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
65. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo
66. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node
67. CTL priming by CD8(+) and CD8(-) dendritic cells in vivo
68. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes
69. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
70. Reciprocal control of T helper cell and dendritic cell differentiation
71. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
72. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells
73. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
74. - (myeloid) dendritic cells differentially regulate vascularized organ allograft survival
75. - cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers
76. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
77. Differentiation of T regulatory cells by immature dendritic cells
78. Dendritic cells and prospects for transplantation tolerance
79. Anergic T cells inhibit the antigen-presenting function of dendritic cells
80. T suppressor lymphocytes inhibit NF-κB-mediated transcription of CD86 gene in APC
81. T-cell regulation and transplant tolerance
82. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells
83. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells
84. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells
85. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells
86. Role of re-entry of in-vivo alloMHC peptide-activated T cells into the adult thymus in acquired systemic tolerance
87. Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig)
88. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
89. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells
90. A dendritic cell line genetically modified to express CTLA4-Ig as a means to prolong islet allograft survival
91. Prolongation of cardiac allograft survival using dendritic cells treated with NF-κB decoy oligodeoxyribonucleotides
92. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β
93. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients
94. Donor-specific dendritic cells modulate cardiac allograft rejection
95. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumor rejection
96. Adenoviruses activate human dendritic cells without polarization towards a T-helper type 1-inducing subset
97. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway
98. Highly efficient transduction of human monocyte-derived dendritic cells with B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells
99. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells
100. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness
101. Feasibility of CTLA4-Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce allogeneic - Specific T cell anergy in vitro
102. Viral vectors for dendritic cell-based immunotherapy
103. Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions
104. Direct differentiation of dendritic cells from mouse embryonic stem cells